NCT02342717View on ClinicalTrials.gov

Relative Bioavailability of a Single Oral Dose of BI 425809 When Administered Alone or in Combination With Multiple Oral Doses of Itraconazole in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Healthy
Interventions
DRUG

BI 425809

single dose BI 425809 tablet

DRUG

Itraconazole

multiple doses of Itraconazole capsules

DRUG

BI 425809

single dose BI 425809 tablet

Trial Locations (1)

Unknown

1346.10.1 Boehringer Ingelheim Investigational Site, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY